By vanstrokepr on October 28, 2015
The VSP is now actively recruiting for DATAS-II: Dabigatran following Transient ischemic attack and minor Stroke. The trial is funded by CIHR.
For more information visit:
https://clinicaltrials.gov/ct2/show/NCT02295826
Posted in News